Single Arm Study of the Combination of Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Bevacizumab (Primary) ; Docetaxel; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms AINO
- 01 Dec 2016 Results published in the Anticancer Research
- 27 Apr 2016 Status changed from recruiting to completed.
- 20 Mar 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 ClinicalTrials.gov.